Spermidine
Sponsors
Medical University of Graz, University of California, Davis, Chrysea Labs Lda, University of Aarhus, West China Hospital
Conditions
AgingAutophagyCardiovascular DiseasesCognition DisorderCognitive ImpairmentDiabetes Mellitus, Type 2Diastolic DysfunctionDietary Habits
Phase 1
A Randomized Controlled Trial of Spermidine for the Prevention of Radiation-Induced Xerostomia in Head and Neck Squamous Cell Carcinoma (Including Nasopharyngeal Carcinoma)
RecruitingNCT07035626
Start: 2025-06-25End: 2026-06-08Target: 58Updated: 2025-06-26
A Study of Exercise and Pharmacologic Intervention on Systemic Inflammation
RecruitingNCT07058974
Start: 2025-08-25End: 2026-07-01Target: 22Updated: 2025-09-25
Phase 2
Phase 3
Unknown Phase
Absorption and Digestion Kinetics of Human Metabolites
CompletedNCT05017428
Start: 2021-04-08End: 2021-07-01Updated: 2021-08-23
Bioavailability of Spermidine in Healthy Males
Active, not recruitingNCT06017219
Start: 2023-05-05End: 2024-12-14Target: 6Updated: 2024-08-30
Iterative Design Trial to Assess Dietary Supplements and Other Aging-targeted Therapies
Enrolling by invitationNCT07202403
Start: 2025-09-30End: 2031-09-30Target: 10Updated: 2025-10-01
Assessment of the Effects and Safety of Spermidine Supplementation on Blood Lipids and Body Weight in Overweight or Obese Individuals With Hyperlipidemia
RecruitingNCT07662330
Start: 2026-01-01End: 2027-01-31Target: 50Updated: 2026-06-23
Effects of Miricell Supplementation on Biomarkers of Healthy Aging and Autophagy
RecruitingNCT07675200
Start: 2026-01-09End: 2026-09-01Target: 70Updated: 2026-06-30